Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 19:39
Royalty Pharma Price to Book Value: 1.668 for Nov. 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 1.662 |
| November 14, 2024 | 1.654 |
| November 13, 2024 | 1.672 |
| November 12, 2024 | 1.682 |
| November 11, 2024 | 1.705 |
| November 08, 2024 | 1.695 |
| November 07, 2024 | 1.715 |
| November 06, 2024 | 1.723 |
| November 05, 2024 | 1.781 |
| November 04, 2024 | 1.759 |
| November 01, 2024 | 1.753 |
| October 31, 2024 | 1.753 |
| October 30, 2024 | 1.765 |
| October 29, 2024 | 1.763 |
| October 28, 2024 | 1.770 |
| October 25, 2024 | 1.750 |
| October 24, 2024 | 1.771 |
| October 23, 2024 | 1.776 |
| October 22, 2024 | 1.777 |
| October 21, 2024 | 1.802 |
| October 18, 2024 | 1.817 |
| October 17, 2024 | 1.821 |
| October 16, 2024 | 1.832 |
| October 15, 2024 | 1.808 |
| October 14, 2024 | 1.810 |
| Date | Value |
|---|---|
| October 11, 2024 | 1.819 |
| October 10, 2024 | 1.785 |
| October 09, 2024 | 1.791 |
| October 08, 2024 | 1.776 |
| October 07, 2024 | 1.79 |
| October 04, 2024 | 1.802 |
| October 03, 2024 | 1.802 |
| October 02, 2024 | 1.834 |
| October 01, 2024 | 1.843 |
| September 30, 2024 | 1.837 |
| September 27, 2024 | 1.952 |
| September 26, 2024 | 1.951 |
| September 25, 2024 | 1.913 |
| September 24, 2024 | 1.917 |
| September 23, 2024 | 1.917 |
| September 20, 2024 | 1.906 |
| September 19, 2024 | 1.937 |
| September 18, 2024 | 1.952 |
| September 17, 2024 | 1.954 |
| September 16, 2024 | 1.956 |
| September 13, 2024 | 1.918 |
| September 12, 2024 | 1.906 |
| September 11, 2024 | 1.922 |
| September 10, 2024 | 1.942 |
| September 09, 2024 | 1.945 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.654
Minimum
Nov 14 2024
4.324
Maximum
Dec 29 2020
2.797
Average
2.918
Median
Sep 27 2022
Price to Book Value Benchmarks
| Geron Corp | 7.787 |
| Amicus Therapeutics Inc | 16.15 |
| Ionis Pharmaceuticals Inc | 8.041 |
| Arbutus Biopharma Corp | 6.258 |
| Syndax Pharmaceuticals Inc | 3.749 |
Price to Book Value Related Metrics
| PE Ratio | 10.12 |
| PS Ratio | 6.786 |
| Price to Free Cash Flow | 5.494 |
| Price | 25.80 |
| Earnings Yield | 9.89% |
| Market Cap | 11.46B |
| Operating PE Ratio | 9.961 |
| Normalized PE Ratio | 13.16 |